Google Drops 12.64% Amid Cash Flow Concerns, Eli Lilly Reaches Record High

After the U.S. stock market closed on October 29, a clear divergence emerged among individual stocks and sectors. Google fell 12.64%, wiping out approximately $500 billion in market value in a single day—the largest single-day decline since its 2004 IPO (as reported). Following suit, Intel and Amazon also saw significant after-hours declines after releasing their earnings reports. In contrast to the weakness in tech stocks, Eli Lilly rose 6.57% to a new all-time high, while the healthcare, financial, and energy sectors generally closed higher. The Nasdaq dropped 1.38%, the S&P 500 fell 0.30%, and the Dow declined 0.25% (CNN summary), indicating no broad-based panic at the index level; what truly shifted was investors’ assessment of the quality of corporate earnings. Amid growing investment in AI, the market began placing greater emphasis on when these investments would translate into tangible cash returns—a theme that permeated all market movements that day.

Google’s earnings report actually showed strong revenue performance. Third-quarter revenue reached $127.577 billion, a 25% year-over-year increase, marking the 13th consecutive quarter of double-digit growth. Google Cloud revenue amounted to $30.709 billion, up 103% year-over-year, significantly exceeding market expectations. This indicates that enterprise demand for cloud computing and AI infrastructure remains robust, with no noticeable slowdown in demand across the AI value chain. What truly disappointed the market was the slowing growth in advertising revenue and the cash flow pressure resulting from continued expansion in capital expenditures.

The issue with the advertising business is that users are increasingly using search, but commercial monetization has not kept pace. In Q3, search and other advertising revenue reached $63.35 billion, a 12% year-over-year increase, falling short of the market expectation of nearly $65 billion and marking a noticeable decline from the 17% growth rate in the previous quarter. Google also disclosed that search volume growth has reached its highest level in nearly five years—users are not reducing their searches, yet this growth in search volume has not translated into proportional increases in advertising revenue. According to reports from outlets such as The Economist, queries generated through certain AI models have lower advertising monetization efficiency compared to traditional search results pages. As users increasingly become accustomed to obtaining answers directly through AI, Google must address not only how to encourage more people to use AI, but also how to preserve the commercial value of its advertising business within this new interaction model.

The core driver of this decline is not the slowing growth in advertising, but the cash flow pressure from capital expenditures. In Q3, Google’s capital expenditures reached $51.355 billion, a year-over-year increase of approximately 114%, exceeding its operating cash flow of $42.29 billion for the quarter. As a result, free cash flow turned into a net outflow of $9.065 billion, while the market had expected a modest net inflow of around $2.7 billion. More notably, this is not a one-time fluctuation. In Q2, Google’s free cash flow also posted a net outflow of $5.855 billion, compared to a net inflow of $24.461 billion in the same period last year, with the cash flow gap continuing to widen. Management also indicated that capital expenditures in 2027 will remain higher than in 2026, without providing a clear timeline for when investment peaks or spending will plateau.

An increase in capital expenditures is not inherently negative. For companies in cloud computing and AI infrastructure, building data centers ahead of time, purchasing servers, and expanding network capacity are crucial strategies for capturing long-term market share. The key lies in whether these new investments can generate sufficient revenue and profit. If the cloud business continues to grow rapidly and profit margins improve with scale, the current cash flow pressure may merely be a temporary phase of expansion. However, if capital expenditures consistently outpace operating cash flow and cloud revenue growth fails to translate into corresponding cash returns, investors must reassess the company’s future free cash flow and return on capital. Google’s recent valuation repricing is not a reflection of its AI capabilities, but rather concerns over the payback period of its AI investments.

Both Intel and Amazon traded lower after hours, but the pressures facing each company should be viewed separately. Intel’s stock dropped more than 20% in after-hours trading, but its quarterly results were actually solid: third-quarter revenue reached $16.513 billion, up 21% year-over-year, with data center revenue surging 78%, indicating strong demand for AI inference server chips. The real drag on the stock price came from its fourth-quarter guidance: revenue is projected at $15–16 billion, below Wall Street’s expectation of approximately $17 billion, and gross margin guidance was lowered to 37%. Management cited several factors, including weak PC demand potentially persisting into the first half of 2027, rising costs due to higher memory chip prices, and an estimated $300 million impact on fourth-quarter revenue from an incident at its Israeli facility.

More critically, expectations were too high. Before the earnings report, Intel’s stock had already risen over 130% year-to-date; meeting quarterly targets wasn’t enough—any guidance below expectations risked triggering profit-taking. After hours, the stock plunged over 20%, closing at a final snapshot of $70.87, roughly 25.8% below its closing price. Thus, this decline appears more like a valuation adjustment driven by guidance disappointment叠加 high expectations, rather than a simple repricing of AI capital expenditures. However, it also highlights that market tolerance for AI-related assets is shrinking: merely having an “AI narrative” or distant demand projections is no longer sufficient to command a valuation premium—companies must deliver concrete earnings and credible guidance.

After hours, Amazon's stock dropped more than 7%. Amazon faces the same capital return challenges as Google, with pressure centered on revenue, cash flow, and capital expenditures. Third-quarter total revenue was $201.9 billion, slightly below market expectations. AWS revenue reached $46 billion, up 39.3% year-over-year, higher than the previous quarter’s 37%, but still below the over-40% threshold some analysts had anticipated; guidance for the holiday season was also weak, leading to concerns about near-term revenue growth. More critical than revenue is cash flow. Over the past 12 months, operating cash flow was $168.3 billion, up 29% year-over-year, but free cash flow netted a negative $42.4 billion. The vast majority of this gap stems from capital expenditures on data centers and other investments consuming operating cash.

Amazon has not scaled back its investments and remains on track with its $220 billion capital expenditure plan for 2026, with CEO Jassy stating that spending will increase significantly in 2027. For investors, AWS still holds strong growth potential, but achieving returns will require continued substantial investment in the future. Revenue falling short of expectations, weak holiday guidance, deeply negative free cash flow, and expectations of further increased capital spending have created primary post-earnings pressures. After-hours shares briefly dropped more than 7%, with media reports citing declines of over 12%; the final snapshot price was $225.99, approximately 4.2% below the closing price.

When comparing Google and Amazon, the market’s concerns have shifted. Demand for AI is not the issue; rather, the concern is that infrastructure development may be entering a phase where investment scales are growing larger but payback periods remain unclear. According to media reports from outlets like The New York Times, Google, Amazon, Microsoft, and Meta are projected to combine for over $720 billion in capital expenditures this year—roughly triple the amount from two years ago. Three of the four companies have already turned negative free cash flow, and Meta has posted its first-ever quarterly negative free cash flow since going public. As upstream and cloud service providers ramp up investments, the market naturally asks: How much return will such massive capital spending ultimately generate for shareholders?

While tech giants are busy explaining capital expenditures and returns on investment, Eli Lilly delivered a markedly different earnings report. The company reported third-quarter revenue of $24.397 billion, a 39% year-over-year increase, surpassing the market expectation of approximately $22.6 billion. Adjusted earnings per share came in at $7.48, also exceeding the expected $6.49. Core growth continued to be driven by GLP-1 drugs, with Mounjaro generating global revenue of $10.72 billion, up 65% year-over-year, and Zepbound contributing $5.35 billion in revenue, up 49% year-over-year—combined, these two products accounted for approximately 66% of quarterly revenue. As sales continue to exceed expectations, the company raised its full-year revenue guidance from $85 billion to $87 billion to $91 billion to $92 billion—this is the third upward revision this year (based on company earnings reports and media summaries).

The difference between Eli Lilly and Google lies not in growth rates, but in how growth is realized. Google must first invest tens of billions of dollars in building data centers and purchasing equipment, then gradually recoup costs through cloud services and AI products. In contrast, Eli Lilly’s core revenue comes directly from existing drug sales and prescription demand: in the third quarter, the company generated $8.219 billion in net free cash flow, with sales volume up 53%. Although net pricing declined by approximately 15% due to factors like医保 access, the sales growth was still sufficient to drive overall revenue growth of 39%. As markets begin to reassess corporate capital returns, Eli Lilly’s business model—directly converting product demand into revenue and cash flow—is naturally more likely to attract capital attention.

Of course, strong cash flow performance does not mean Eli Lilly has no valuation risk. Previously, its forward P/E ratio was estimated at around 45 times, indicating that the valuation is not cheap. Medicare access could continue to pressure net prices, and competition in the weight-loss drug market may impact future market share. For investors looking to track Eli Lilly, the key focus moving forward should be whether prescription volumes and sales growth can be sustained, whether the decline in net prices is accelerating faster than sales growth, and whether revenue guidance continues to align with free cash flow. Especially after the stock has reached an all-time high, investors should not chase short-term gains solely based on capital inflows into the healthcare sector; further support from volume-price data and earnings expectations is still needed.

Google and Eli Lilly moved in opposite directions—not just as individual stocks, but also reflected in broader sector movements that day. The healthcare sector performed strongly, with Moderna rising 4.01%, Merck up 3.83%, and Amgen gaining 1.97%. Most financial stocks closed higher, with JPMorgan Chase up 1.26%. Energy stocks also edged higher, with ExxonMobil rising 0.70% and Chevron up 0.99% (market data feed). Brent crude and WTI held near $114 and $102 per barrel, respectively (report summary), yet energy stocks did not surge in line with oil prices, suggesting that investor focus that day extended beyond geopolitical premiums to include the tangible operating cash flows energy companies were already generating.

Healthcare, finance, and energy generate profits in different ways, but they share one commonality: it’s relatively easy to see where their revenue and cash flow come from. Healthcare relies on drug sales and prescription demand; banks depend on interest spreads, transactions, and lending; energy is driven by oil prices, production levels, and cost control. Each faces its own risks—banks worry about deteriorating credit quality, energy companies fear falling oil prices, and pharmaceutical firms face pressure from drug pricing and competition. Yet compared to technology companies still heavily investing in AI infrastructure, these industries have more predictable paths to profitability. In a phase where investors are refocusing on current cash flows, this clarity alone attracts capital.

Institutional capital data also provides supporting evidence. Goldman Sachs’ positioning tracker shows that hedge funds collectively increased their holdings in the healthcare sector by $1.69 billion over the past two weeks, while reducing exposure to semiconductors. EPFR data indicates that U.S. equity funds focused on healthcare saw net inflows of $4.72 billion over the same period, representing one of the stronger rebound levels this year. However, two weeks of inflows are insufficient to confirm a sustained long-term shift from technology to healthcare. A more reasonable interpretation is that institutions are increasing allocations to sectors like healthcare, where earnings visibility is relatively clearer. Future developments will depend on whether healthcare funds can continue attracting capital and whether semiconductor reductions further expand. Baird strategists hold a similar view: volatility in the AI narrative does not imply a breakdown of the broader market’s growth logic; capital may instead be shifting from a few giants whose valuations rely heavily on high capital expenditures toward assets with more diversified sources of profitability.

Therefore, the current market situation should not be simplistically viewed as a capital battle between AI and non-AI sectors. Demand for AI remains strong, as evidenced by Google Cloud’s revenue growth of 103% and Amazon AWS’s growth of 39.3%, both indicating that enterprises’ demand for cloud computing and AI computing power has not diminished. What has changed is that the market is now distinguishing between “industry demand” and “corporate profitability.” While AI infrastructure providers can generate revenue through orders and product sales, it does not mean all cloud service providers can recoup their data center construction costs in the short term. Companies that are more likely to sustain valuation premiums in the future are those that can demonstrate their investments ultimately translate into profits and free cash flow—not necessarily those with the largest AI spending.

For investors, it is more valuable right now to track the next three key milestones that can validate market sentiment than to speculate on when Google might rebound. First is NVIDIA’s earnings report in mid-November, which will directly test whether demand for AI computing power remains strong. Key indicators to watch include data center revenue, order volumes and delivery figures, and whether gross margins can remain stable. If revenue and orders continue to exceed expectations, it suggests sustained demand for AI infrastructure, making it less likely that profit expectations across the computing power supply chain will be quickly revised downward. However, if order growth slows significantly or gross margins are pressured by product mix and competition, the market may further lower its expectations for AI hardware growth. Even if NVIDIA beats expectations, this does not automatically resolve cloud giants’ return-on-investment concerns—profitability for computing power suppliers and capital expenditure recovery for cloud service providers remain two distinct financial issues.

The second node is the capital expenditure guidance from the next generation of cloud giants, which may be more important than revenue growth alone. For Google, Amazon, Microsoft, and Meta, investors need to examine capital expenditures, cloud revenue, operating margins, and free cash flow together. If cloud revenue continues to grow while capital expenditure growth gradually slows and operating cash flow begins to better cover investment spending, it suggests that AI infrastructure investment may be transitioning from the deployment phase to the returns phase, potentially providing renewed valuation support for tech stocks. Conversely, if companies continue to raise their capital expenditure plans without corresponding improvements in cloud growth, and the free cash flow gap widens further, any stock price rebound cannot be taken as evidence that valuation pressures have been resolved.

The third key event is the Federal Reserve’s interest rate meeting on December 9, which will impact the relative valuation of cash flows across different maturities. When interest rates remain elevated, profits that will be realized years in the future are discounted more heavily to their present value, making high-valuation growth stocks reliant on distant returns more vulnerable to pressure. In contrast, companies with relatively stable earnings and dividends may gain a relative advantage. At that time, it will be necessary to assess whether the cost of capital will continue to rise by analyzing the rate decision, the dot plot, Powell’s remarks, and changes in U.S. Treasury yields. However, rate cuts do not necessarily benefit technology stocks—if cuts are triggered by a sharp economic slowdown, corporate revenues and profit expectations may decline in tandem, and any improvement in valuations might not offset deteriorating fundamentals.

From a directional perspective, the current observation scope can be divided into three groups. The first group consists of AI infrastructure and cloud computing leaders, where the focus is not solely on the magnitude of stock price corrections, but rather on validating demand for computing power and capital returns. For NVIDIA and AMD, monitor orders, data center revenue, and gross margins; for cloud giants, track revenue growth in cloud services, profitability, capital expenditures, and free cash flow. The second group comprises healthcare assets, where key metrics for GLP-1 products include prescription volumes, net selling prices, and full-year guidance; other pharmaceutical companies should assess profit sustainability based on their respective product pipelines and sales performance. The third group includes financial and energy assets: for JPMorgan Chase (JPM), monitor net interest margin, credit losses, and trading income; for traditional energy companies, focus on oil prices, production levels, capital discipline, and free cash flow.

These sectors cannot be simply grouped into a single defensive allocation. Eli Lilly still faces valuation and competitive risks, banks must navigate credit cycles, and energy companies are affected by oil price volatility. A more prudent approach is to create watchlists based on each sector’s distinct profit drivers and assess whether to increase allocation weights by analyzing earnings reports and changes in cash flows.

Overall, the key shift in this market cycle is that investors are raising their expectations for AI’s business returns—funds have not abandoned AI. As long as demand for computing power continues to grow, the long-term investment opportunities in the AI industry won’t disappear due to one or two earnings reports. However, for companies with ongoing capital expenditures and unchanged cash flow, the market may no longer be willing to assign high valuations based solely on distant growth narratives. In contrast, sectors with clearer paths to profitability—such as healthcare, finance, and energy—may continue to attract capital. What truly matters going forward is who can turn these investments into profits and free cash flow first, not just who announces the largest AI investment plans.

• Google: Market and Financial Data, October 30, 2026. Close at $283.82, down 12.64%, market cap at $3.46 trillion, with approximately $500 billion evaporated according to the interface. Q3 revenue: $127.577 billion; operating cash flow: $42.29 billion; free cash flow: -$9.065 billion; capital expenditures: $51.355 billion, derived from the difference between two periods. Earnings per share and AI monetization efficiency are sourced from earnings reports and summaries by CNBC and The Economist.
• Intel: According to reports from FT, WSJ, and others, dated October 30, 2026. Q3 revenue was $16.513 billion, up 21%, meeting expectations; data center revenue increased 78%. Q4 guidance of $15–16 billion is below the expected $17 billion. Gross margin guidance is 37%. After-hours snapshot: $70.87, down 25.8% from closing price.
• Amazon: Report as of October 30, 2026. Revenue of $201.9 billion slightly below expectations; AWS revenue of $46 billion increased 39.3%. TTM free cash flow negative $42.4 billion; 2026 capital expenditures of $220 billion. Post-market snapshot: $225.99, down 4.2%, previously fell over 12%—unverified.
• Eli Lilly: Market and Financial Update. Closed at $1,373, up 6.57% to a new high, with a market cap of $1.29 trillion. Q3 revenue reached $24.397 billion, up 39%; EPS was $7.48 (GAAP: $7.23); free cash flow was $8.219 billion; guidance raised for the third time this year to $91–92 billion.
• Sector and Fund Flows: Individual stock movements are sourced from market data feeds; indices are reported by CNN. Goldman Sachs holdings tracking and EPFR medical fund inflows are institutional data summaries.
• The four major companies spent over $720 billion on capital expenditures this year, with three turning free cash flow negative: as reported by The New York Times and others. Brent crude is around $114, and WTI is around $102, according to reports dated October 29.

The content of this article is provided solely for general information and market commentary purposes, based on publicly available information as of the time referenced herein. Market data, expectations, and probabilities mentioned may change due to market conditions. Opinions and investment strategies cited from third-party institutions, analysts, or other individuals reflect only their views at a specific point in time and do not represent BIT’s views or recommendations. This article does not constitute investment advice, investment research, an offer, solicitation, or recommendation for any securities, investment products, or trading strategies, and should not be used as the basis for any investment decision. Financial markets involve risks; security prices and market performance may fluctuate, and historical performance or past market trends do not indicate or guarantee future results. Investors should independently assess relevant risks based on their own circumstances and seek professional advice when necessary. BIT’s Hong Kong stock trading services are not available to users residing in Hong Kong or other restricted jurisdictions.